Literature DB >> 35098410

Circ_0009910 Serves as miR-361-3p Sponge to Promote the Proliferation, Metastasis, and Glycolysis of Gastric Cancer via Regulating SNRPA.

Jun Liu1, Juyuan Li2, Yu Su1, Zhen Ma1, Shun Yu1, Yiming He3.   

Abstract

Circular RNA (circRNA) has been proved to be a key regulator of gastric cancer (GC) progression. Circ_0009910 was found to be highly expressed in GC and related to GC progression, but its role and mechanism in GC progression need to be further improved. Our study aims to further reveal circ_0009910 roles in GC progression and elucidate its potential molecular mechanism. The expression of circ_0009910, microRNA (miR)-361-3p, and small nuclear ribonucleoprotein polypeptide A (SNRPA) mRNA was measured by quantitative real-time PCR. Protein expression was determined using western blot analysis. Cell proliferation, migration, invasion, and apoptosis were evaluated using EDU staining, transwell assay, and flow cytometry. Cell glycolysis were assessed by detecting glucose consumption, lactate production, and glycolysis-related markers protein expression. The relationship between miR-361-3p and circ_0009910 or SNRPA was confirmed by RNA pull-down assay and dual-luciferase reporter assay. In vivo experiments were performed to explore the effect of circ_0009910 silencing on GC tumorigenesis. Circ_0009910 and SNRPA were upregulated in GC tumor tissues and cells. Knockdown of circ_0009910 or SNRPA could inhibit GC cell proliferation, migration, invasion, glycolysis, and promote apoptosis. Circ_0009910 could sponge miR-361-3p, and miR-361-3p could target SNRPA. Further experiments confirmed that circ_0009910 positively regulated SNRPA by sponging miR-361-3p. Additionally, SNRPA overexpression abolished the negative regulation of circ_0009910 silencing on GC progression. Furthermore, silenced circ_0009910 also reduced GC tumorigenesis in vivo. Our data showed that circ_0009910 might be a target for GC treatment, which could promote GC proliferation, metastasis, and glycolysis by the miR-361-3p/SNRPA axis.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Gastric cancer; SNRPA; circ_0009910; miR-361-3p

Mesh:

Substances:

Year:  2022        PMID: 35098410     DOI: 10.1007/s10528-021-10168-2

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   2.220


  6 in total

1.  Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray.

Authors:  Yuefang Liu; Xiaojing Zhu; Jin Zhu; Shibing Liao; Qi Tang; Kaikun Liu; Xiaohong Guan; Jianping Zhang; Zhenqing Feng
Journal:  Oncol Rep       Date:  2007-10       Impact factor: 3.906

2.  Circ_0009910 regulates growth and metastasis and is associated with poor prognosis in gastric cancer.

Authors:  M Liu; K-D Liu; L Zhang; J Cai; H-W Yao; Y-K Bai; Z-T Zhang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-12       Impact factor: 3.507

3.  Circ_0009910 promotes proliferation and metastasis of hepatocellular carcinoma cells through miR-335-5p/ROCK1 axis.

Authors:  H-W Li; J Liu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-02       Impact factor: 3.507

Review 4.  Progress in the treatment of advanced gastric cancer.

Authors:  Zheyu Song; Yuanyu Wu; Jiebing Yang; Dingquan Yang; Xuedong Fang
Journal:  Tumour Biol       Date:  2017-07

5.  LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.

Authors:  Jun Xu; Baohua Yang; Lifeng Wang; Yunheng Zhu; Xiuxiang Zhu; Ziyin Xia; Zhen Zhao; Ling Xu
Journal:  Cell Prolif       Date:  2020-06-09       Impact factor: 6.831

6.  The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.

Authors:  Zhao Liu; Lili Pan; Xiaofang Yan; Xiuna Duan
Journal:  FEBS Open Bio       Date:  2020-12-31       Impact factor: 2.792

  6 in total
  1 in total

1.  Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma.

Authors:  Youfu Zhang; Xuyang Wang; Huaxiang Wang; Yi Jiang; Zhidan Xu; Laibang Luo
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.